Phase II Trial of Herceptin Concurrent With External Beam Radiation Following Neoadjuvant Chemotherapy for the Treatment of HER2 Over-Expressing Breast Cancer.

Trial Profile

Phase II Trial of Herceptin Concurrent With External Beam Radiation Following Neoadjuvant Chemotherapy for the Treatment of HER2 Over-Expressing Breast Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Aug 2012

At a glance

  • Drugs Trastuzumab (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Apr 2012 Actual patients number is 19 as reported by ClinicalTrials.gov.
    • 23 Apr 2012 Actual patients number is 19 as reported by ClinicalTrials.gov.
    • 09 Dec 2009 Planned number of patients changed from 35 to 40 as reported by ClinicalTrials.gov. (NCT00943410).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top